Literature DB >> 30306435

Promoting 'Equitable Access' to PrEP in Australia: Taking Account of Stakeholder Perspectives.

Christy Newman1, Shana Hughes2, Asha Persson3, Hong-Ha M Truong2, Martin Holt3.   

Abstract

As evidence of the safety and effectiveness of HIV pre-exposure prophylaxis (PrEP) has grown, so has attention to the views of prospective users and providers. However, far less attention has been paid to understanding the perspectives of other stakeholders in the rollout of PrEP access programs. We conducted 21 semi-structured qualitative interviews in 2017 with key stakeholders working across the policy, advocacy, research and/or clinical dimensions of the Australian HIV response, before federal support for a subsidised access scheme was achieved. Our analysis explored three areas of shared concern: who is a suitable candidate for PrEP; why are disparities in PrEP access important; and how can disparities be addressed? In examining how this diverse group of professionals grappled with the challenges of promoting 'equitable access' to PrEP in an increasingly resource rationed health system, we can see how the principles believed to underpin the Australian response to HIV were both reaffirmed and challenged through this period of significant change.

Keywords:  Access; Australia; Equity; HIV pre-exposure prophylaxis (PrEP); Qualitative research

Mesh:

Year:  2019        PMID: 30306435     DOI: 10.1007/s10461-018-2311-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  2 in total

1.  "How PrEPared are you?": Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in Australia.

Authors:  Budiadi Sudarto; Eric P F Chow; Nicholas Medland; Christopher K Fairley; Edwina J Wright; Jude Armishaw; Brian Price; Tiffany R Phillips; Jason J Ong
Journal:  Front Public Health       Date:  2022-08-19

2.  Strategies to support HIV literacy in the roll-out of pre-exposure prophylaxis in Scotland: findings from qualitative research with clinical and community practitioners.

Authors:  Ingrid Young; George Valiotis
Journal:  BMJ Open       Date:  2020-04-28       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.